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ORIGINAL ARTICLE
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ABSTRACT
Objective: To analyze if there is any relation between functional capacity 
assessed by subjective and objective methods regarding the current state 
and after clinical treatment in patients with intermittent claudication. 
Methods: A total of 500 patients with intermittent claudication were 
enrolled. All patients underwent clinical examination and a functional 
evaluation by subjective (clinical visit) and objective method (treadmill 
test). Additionally, 50 patients were selected to evaluate the effect of 
clinical treatment by subjective and objective methods in relation to 
functional capacity. Results: Out of 500 patients, only 60 (12.0%) had 
similar results in both methods. The remaining, that is 440 patients 
(88.0%) had subject values in disagreement with stress test findings. 
Regarding the clinical effect of the treatment on the functional outcomes, 
results were similar in both methods (χ2=1.7; p=0.427). Conclusion: 
Although the subjective method overestimates the functional capacity 
when compared to the objective method, no significant differences were 
observed between both methods when analyzing the effect of clinical 
treatment. Thus, the subjective method provides similar information as 
compared with objective method, in monitoring the clinical treatment of 
patients with intermittent claudication.
Keywords: Peripheral arterial disease/therapy; Exercise test; Walking
RESUMO
Objetivo: Verificar se há relação entre a medida da capacidade funcional 
avaliada subjetiva e objetivamente em relação ao estado atual e após 
tratamento clínico em pacientes com claudicação intermitente. Métodos: 
Foram recrutados 500 pacientes com claudicação intermitente. Todos 
realizaram exame clínico e foram submetidos a uma avaliação funcional 
por meio do método subjetivo (consulta clínica) e objetivo (teste de 
esteira). Adicionalmente, 50 pacientes foram selecionados para se 
avaliar o efeito do tratamento clínico, pelos métodos subjetivo e objetivo, 
em relação à capacidade funcional. Resultados: Dos 500 pacientes 
selecionados, somente 60 (12,0%) apresentaram valores referidos 
e observados similares. Os demais pacientes, ou seja, 440 (88,0%) 
apresentaram valores relatados discordantes em relação àqueles obtidos 
no teste de esforço. Com relação ao efeito do tratamento clínico em 
relação à capacidade funcional, os resultados foram similares entre 
ambos os métodos (χ2=1,7; p=0,427). Conclusão: Apesar de o método 
subjetivo superestimar os valores de capacidade funcional, quando 
comparados ao método objetivo, não foram observadas diferenças 
significantes entre ambos os métodos, quando se analisou o efeito do 
tratamento clínico. Assim, o método subjetivo fornece informações 
similares em comparação à medida objetiva no acompanhamento do 
tratamento clínico de pacientes com claudicação intermitente.
Descritores: Doença arterial periférica/terapia; Teste de esforço; 
Caminhada
INTRODUCTION
Peripheral artery disease (PAD) includes a series of 
structural dysfunctions leading to reduced lumen of 
trunk vessels in the lower limbs, mostly because of 
atherosclerosis(1), which affects approximately 10.5% 
einstein. 2013;11(4):495-9
496 Cucato GG, Zerati AE, Chehuen MR, Ritti-Dias RM, Saez G, Ragazzo L, Puech-Leão P, Wolosker N
of the Brazilian population aged over 18 years(2). One 
important feature of PAD is the decreased peripheral 
artery blood flow, which frequently leads to symptoms of 
pain, cramps, burning or muscular fatigue when walking(3-5). 
This set of symptoms is known as intermittent claudication 
(IC) and it affects 25 to 33% of individuals with PAD(4,5). 
The presence of IC symptoms results in reduced 
physical activities(6), thus interfering in functional capacity(7), 
health and quality of life(8), and ultimately death due to 
cardiovascular disease(9,10). On the other hand, with the 
purpose of promoting benefits to these patients, physical 
exercise, associated with drug treatment, is the initial 
medical treatment recommended for them, considering 
their significant results in improving functional capacity(11), 
quality of life(12) and associated comorbidities(13,14), with 
surgical(15) or endovascular(16) treatment being performed 
only when clinical treatment does not work effectively.
Because of marked functional limitation imposed 
by the IC symptoms, measurements of claudication 
distance and total walking distance (TWD) have been 
widely used as clinical indicators(4,5). Until a few years 
ago, evaluation of these measurements was carried out 
only subjectively, e.g., distances walked depended only 
on the distance reported by the patients, which left 
doubts in regard to the method reliability, in addition to 
the measuring the maximum distance walked, especially 
for scientific evaluation of data. Subsequently in an 
attempt to obtain more precise and objective data, 
standardized tests on a treadmill started being used, 
and nowadays they are considered the gold standard for 
evaluating the functional capacity and following up of 
clinical parameters of patients with IC(17). 
However, treadmill tests cannot always be offered 
at healthcare units because of their operational cost 
and required time to perform; therefore, values of 
functional capacity obtained through TWD reported by 
the patients remain widely used in the clinical practice, 
with objective tests being relegated only to groups that 
scientifically investigate this illness. However, it is still 
not clear if the functional capacity figures obtained by 
this method are different than those quantified by the 
objective method. For this reason, it is necessary to 
investigate if both methods provide similar information 
in regard to the clinical progression of patients submitted 
to treatment, thus helping physicians choose the type of 
management for this type of patient.
OBJECTIVE
To compare the functional capacity responses assessed 
by the subjective method (values reported by the 
patients) and quantified by the objective method 
(values quantified in a treadmill test); to analyze if both 
assessment methods present similar values in regard 
to functional capacity in patients submitted to clinical 
treatment.
METHODS
In the period between December 2008 and December 
2012, patients with PAD and symptoms of IC were 
enrolled at the Department of Vascular Surgery, of 
Hospital das Clínicas da Faculdade de Medicina da 
Universidade de São Paulo (USP). This was a prospective, 
non-randomized and uncontrolled study. All patients 
enrolled were submitted to the same experimental 
protocol in accordance with the standards of the 
Ethics Committee on Human Research of Hospital 
das Clínicas da Faculdade de Medicina da USP, under 
number 121,001. 
The inclusion criteria were patients should be able 
to walk on a treadmill or have a medical history of 
experience on this ergometer. Patients excluded from 
the study were those with severe coronary artery disease, 
arterial hypertension or decompensated diabetes 
mellitus, and those submitted to revascularization 
surgery less than one year ago. All patients enrolled 
underwent a clinical examination, medical history 
taking, ankle-brachial index (ABI), and objective and 
subjective evaluations of a TWD.
Diagnosis of peripheral artery disease
Diagnosis of PAD was made based on the following 
criteria: (1) ABI at rest ≤0.90 in one or two limbs; 
(2) palpation of peripheral artery pulses (femoral, 
popliteal, posterior tibial and pedal); (3) Fontaine II 
Classification, with the presence of CI symptoms, such 
as pain, cramps, burning and tingling in lower limbs 
during the walking exercise test(4). 
Assessment of functional capacity
For subjective assessment of functional capacity, during 
a routine medical visit the patients were asked by the 
investigator about their estimate of maximum walking 
capacity through the following question: “What is the 
maximum distance that you think you can walk until 
the symptom of pain prevents you from continuing the 
exercise?”.
For objective assessment of the functional capacity, 
patients were submitted to a walking exercise test 
on a treadmill by using a specific protocol for this 
population(17). The test was carried out at a constant 
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velocity of 3.2km/h and increments of 2% in slope every 
2 minutes, until the patient could no longer walk due to 
the symptoms of pain. The test was interrupted when 
the patients could no longer stand the pain and, at that 
moment, TWD was recorded (in meters). 
Clinical treatment and subjective and objective 
assessments of functional capacity
Of the 500 patients initially enrolled, a sub-sample of 
50 patients was selected with the purpose of analyzing 
the effect of clinical treatment by means of subjective 
and objective methods in relation to functional 
capacity. These patients were instructed to carry out 
clinical treatment in accordance with the international 
and national guidelines for the disease(4,5,18), which 
recommend the control of associated comorbidities 
(hypertension, diabetes mellitus, hypercholesterolemia 
and smoking habit) and to do physical activities 
every day, preferably walking for one hour, aiming at 
reaching the total walking distance in the presence of 
pain (TWD). After three months of treatment, these 
patients returned to hospital and they were reassessed 
by both methods (subjective and objective). 
Statistical analysis
For data analysis, responses were considered similar 
between the objective and subjective methods when 
the values did not exceed 30 meters. For analysis of the 
association between subjective and objective tests of 
the functional capacity and to quantify the changes with 
clinical treatment, a χ2 with p<0.05.was used.
RESULTS
Of the enrolled patients, 500 met the initially proposed 
criteria and they were included in the study. Of those, 
60% (300/500) were male, with mean age of 62 years 
(32 to 88 years), 75.5% had a history of smoking habit, 
and a past history of several comorbidities associated 
with PAD, such as hypertension (63.0%), diabetes 
mellitus (27.5%), angina (19.5%) and acute myocardial 
infarction (17.5%).
In regard to the answers of functional capacity 
between both methods, of the 500 patients included in 
the study, only 60 (12.0%) presented similar values in 
regard to TWD between the subjective and objective 
methods. The other patients, e.g., 440 (88.0%) presented 
discrepant reported values in relation to those obtained 
in the walking test on a treadmill, and in 147 patients 
(29.4%) the reported value was higher than the one 
observed and, in 293 patients (58.6%) the reported 
value was lower than the one observed. These values 
are shown in table 1. 
Regarding the effect of clinical treatment on functional 
capacity, in subjective assessment, out of the 50 patients 
selected, 31 (62%) reported improvement, 12 (24%) 
worsening and 7 (14%) reported stability of functional 
capacity after three months of clinical treatment with 
34 patients (68%) presenting improvement, 7 (14%) 
patients presenting worsening and 9 (18%) patients 
presenting stability when assessed by the objective 
method. Additionally, the effects of clinical treatment 
in functional capacity were similar in the objective and 
subjective methods (χ2=1.7; p=0.427) (Table 2).
DISCUSSION
The main findings in this study were: (1) values of 
functional capacity obtained through the subjective 
method showed differences in relation to those obtained 
by the objective measurement. (2) However, subjective 
and objective methods showed similar results in regard 
to the effect of clinical treatment in relation to the 
functional capacity in patients with IC. The results 
of the current study indicated that the functional 
capacity obtained through the subjective method, was 
different from the measurement obtained with the 
objective method for more than 80% of the patients. 
These results are not surprising since previous studies 
reported a weak relation(19,20) between values assessed 
by the subjective and objective methods of functional 
capacity. Therefore, some hypotheses can be raised 
to explain the possible discrepancies between the 
different methods for assessing functional capacity. It 
Table 2. Comparison of the progress of functional capacity in patients with 
intermittent claudication after 3 months of clinical treatment 
Progress assessment Subjectiven (%)
Objective
n (%)
Improvement 31 (62) 34 (68)
Worsening 12 (24) 7 (14)
Stability 7 (14) 9 (18)
Total 50 (100) 50 (100)
Table 1. Comparison of the values obtained in outpatient visits in patients with 
intermittent claudication (n=500)
Comparison of methods n (%)
Subjective = objective 60 (12.0)
Subjective > objective 147 (29.4)
Subjective < objective 293 (58.6)
Total 500 (100)
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is possible that the specific feature of this disease, e.g., 
the symptoms of IC, present in daily physical activities 
of these patients, may drastically decrease the quality 
of life and health perception, while when asked about 
his/her TWD, these patients can report underestimated 
values of walking to the physician(19). Additionally, since 
most of the patient’s daily activities are carried out on flat 
surface, these features are different from those of the 
walking exercise test used, which was progressive and 
carried out on a treadmill at a fixed velocity of 3.2km 
with increments of 2% in slope per minute. Lastly, 
the physical exertion carried out on a treadmill can 
be quite different from walking during daily physical 
activities and it can be an additional explanation for the 
differences observed in relation to the TWD between 
the two methods. 
On the other hand, although the absolute values of 
TWD have been different between the subjective and 
objective methods, the results related to the follow-
up of patients clinical course showed good agreement 
between them, suggesting that the use of the subjective 
method can be an alternative way for the follow-up of 
clinical progress in patients with IC. The main possible 
explanation for these results would be that the patient, 
while undergoing clinical treatment (walking), has a 
great possibility of increasing his/her TWD and this 
may reflect on improved perception of pain and/or 
health leading to better quality of life; these factors 
could be reported to the physician during the clinical 
consultation. On the other hand, when the patient does 
not undergo clinical treatment, it is possible that his/her 
TWD decreases, resulting in worsening of quality of life 
and self-perception of health, which would affect his/
her response during the clinical consultation(21).
The results of this study may have important clinical 
application, since several health centers do not have 
specific structure for setting up an ergometric assessment 
room or skilled professionals. In addition, a treadmill 
test requires time for being performed, which may not 
be feasible at some vascular surgery centers due to the 
high number of patients seen every day. Therefore, 
functional capacity assessed by the subjective method 
can be an interesting alternative to monitor the patient’s 
clinical status in view of several types of treatment used 
in clinical practice. Additionally, qualitative assessment 
(based on clinical progress) can be considered enough 
for the physician to follow up a patient with claudication, 
especially in cases of reported clinical improvement, 
without the need of using methods of higher operational 
cost for the treatment (treadmill).
This study has some limitations. The use of only 
one question with the subjective method may have 
been insufficient to assess the patient’s current status 
of functional capacity(19). In fact, estimation of the 
functional capacity of walking can be influenced by 
several external factors such as walking velocity, place 
where the patient lives and unilateral or bilateral 
disease – these factors are important and they are 
used in this study. In addition, comparison between 
the subjective and objective methods applied to the 
walking exercise test may present important bias since 
the exercise performed on a treadmill (constant velocity 
and progressive increase in slope) can be quite different 
from the patient’s daily walking activities. Lastly, not 
using questionnaires that assess quality of life did not 
allow assessment of the determinants that could explain 
the similar results between the methods observed after 
the clinical treatment.
CONCLUSION
The subjective method underestimated the values of 
functional capacity when compared with the objective 
method. However, after clinical treatment, both 
methods presented similar values in regard to functional 
capacity. Therefore, the subjective method (functional 
capacity reported by the patient) can be an alternative 
tool for the follow-up and progress of clinical parameters 
of patients with IC submitted to clinical treatment.
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